Nursing guidelines released

Bringing immunology nurses together to improve treatment of patients with immunodeficiency is one of INGID’s core purposes. In a significant new development, INGID has now released the European Nursing Guidelines for Immunoglobulin Administration, which can be accessed through the INGID website. The guidelines are a clear, step-by-step guide for administering immunoglobulin treatment in a full range of patient groups, modalities and locations.

In 2008, discussions at the INGID conference identified the need for clearer guidelines for immunoglobulin administration. With new products coming onto the market (for example immunoglobulin preparations with hyaluronidase for enabling larger subcutaneous infusions) and the use of immunoglobulin therapy to treat a variety of immunodeficiencies as well as autoimmune and inflammatory diseases, it was increasingly difficult for nurses and other clinicians to ensure they were using best practice. Existing guidelines were fragmented and not always in agreement with each other. A group of experienced immunology nurses came together in 2014 and 2015, representing five countries across Europe (the UK, Germany, Sweden, the Netherlands and Norway) and compiled the INGID guidelines from the available evidence and their extensive combined experience.

The resulting guidelines provide user-friendly instructions for the administration of immunoglobulin treatment across the whole spectrum of patient types, treatment indications and treatment formats. Through the easy-to-access web interface, nurses can download a separate stand-alone document for each patient.

Have an adult patient who will be subcutaneously self-administering their immunoglobulin at home? There’s a specific guideline covering everything from patient evaluation, training requirements, likely adverse events and how to manage them, what equipment is required and how the infusions should be documented and periodically evaluated.

Will you be administering immunoglobulin treatment intravenously to a child in hospital? The guideline for this scenario details everything from obtaining consent through to the need for constant monitoring during IV administration to children.

The guidelines aim to improve the quality of care provided to patients receiving immunoglobulin treatment. Focussed on patient safety, removing stress from the procedure, maximising patient benefits while minimising risk and building improved partnerships between patients and clinicians, the guidelines provide a simple framework for immunoglobulin administration in diverse patient groups and clinical settings.

More to explorer


IPOPI Survey

IPOPI is conducting a survey to understand the impact that the COVID-19 pandemic has had, and continues to have, on individuals living with a primary immunodeficiency. The survey aims to

Read More »
African Society for Immunodeficiencies Conference June 2023 Image 3

INGID News June 2023

African Society for Immunodeficiencies Conference June 2023 The 8th biannual ASID conference was held in Casablanca, Morocco from the 14th to 18th of June. It was a very interesting program

Read More »
INGID April 2023 News

INGID News April 2023

World PI Week 2023: Turning real-world data into knowledge for better PID care INGID have joined forces once again with the World PI Week campaign which runs from 22nd April

Read More »